Lipid-Lowering Drink DyslipidemiaTreatment Clinical Observation
Mingxue Zhang
Abstract
Mingxue Zhang
Abstract
[Objective] Observe Lipid-Lowering Drink joint simvastatin contrast with simvastatin treatment dyslipidemia curative effect.[Method] According to the set of standard choose outpatient service dyslipidemia in patients 48 peoples,randomly divided into group A(treatment group-Lipid-Lowering drink joint simvastatin) 24 cases and group B(control group-with simvastatin),24 cases were treatment 60 days,observe the blood fat,liver meritorious service is changes before and after use.[Results] Within two way before and after treatment were markedly improved dyslipidemia level(P0.01),both groups showed good safety,between groups was statistically significant.Lipid-Lowering drink joint simvastatin dyslipidemia treatment had better effects than with simvastatin,in reducing the TC,TG,LDL-C,increase HDL-C all had significant advantage(P0.05).[Conclusion] Lipid-Lowering drink combined statin cholesterol is safe and effective,and better therapeutic use statins.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective] Observe Lipid-Lowering Drink joint simvastatin contrast with simvastatin treatment dyslipidemia curative effect.[Method] According to the set of standard choose outpatient service dyslipidemia in patients 48 peoples,randomly divided into group A(treatment group-Lipid-Lowering drink joint simvastatin) 24 cases and group B(control group-with simvastatin),24 cases were treatment 60 days,observe the blood fat,liver meritorious service is changes before and after use.[Results] Within two way before and after treatment were markedly improved dyslipidemia level(P0.01),both groups showed good safety,between groups was statistically significant.Lipid-Lowering drink joint simvastatin dyslipidemia treatment had better effects than with simvastatin,in reducing the TC,TG,LDL-C,increase HDL-C all had significant advantage(P0.05).[Conclusion] Lipid-Lowering drink combined statin cholesterol is safe and effective,and better therapeutic use statins.
Key concepts: Simvastatin, Dyslipidemia, Medicine, Statin, Lipid profile, Internal medicine, Cholesterol, Gastroenterology